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Unfortunately, after publication of this article [1] it was
noticed that the author list was incorrectly captured during
the production process. The original author list contained
the group “Rheumatic Diseases Portuguese Register”
however this was included erroneously and instead should
only be listed as the affiliation for Helene Canhão. The
correct author list can be seen above and the original
article has been updated to reflect this change.
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